Literature DB >> 33909525

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.

Kirsten E Smith1, Jeffery M Rogers1, Justin C Strickland2, David H Epstein1.   

Abstract

Background: Originally believed to be an atypical antidepressant acting at serotonin transporters, tianeptine is now known to also be an atypical agonist at mu-opioid receptors. Its nonmedical use may be increasing amidst the broader context of novel drug and supplement use.
Objectives: To analyze social-media text from current, former, and prospective tianeptine users for better understanding of their conceptualizations of tianeptine, motives for and patterns of use, and reported benefits and harms.
Methods: Reddit posts were obtained and thematically coded; additional quantitative analyses were conducted.
Results: A total of 210 posts mentioning tianeptine were made between 2012 and 2020. Eighteen thematic categories were identified, 10 of which were consistent with expected themes. Two independent raters coded all text, generating 1,382 unique codes, of which 1,090 were concordant (78.9% interrater agreement). Tianeptine use was frequently associated with use of other drugs, particularly kratom, phenibut, and racetams. People conceptualized and variously used tianeptine as an opioid, antidepressant, and "nootropic" (cognitive enhancer). Between 2014 and 2020, mentions of positive effects decreased, while mentions of adverse effects and withdrawal increased. Motivations for use included substitution or withdrawal mitigation for other drugs (especially opioids) and for kratom itself; self-treatment for psychiatric symptoms; and improvement of quality of life, mood, or performance. Descriptions of tolerance, withdrawal, and addiction were evident. Intravenous use was rare and strongly discouraged, with detrimental effects described.
Conclusion: Tianeptine is recognized as an opioid (though not only an opioid) in online communities. Posts describe benefits, acute risks, and patterns of co-use that warrant greater clinical attention.

Entities:  

Keywords:  Tianeptine; antidepressant; kratom; online drug-using communities; opioids; phenibut; polydrug use; self-treatment

Mesh:

Substances:

Year:  2021        PMID: 33909525      PMCID: PMC8380661          DOI: 10.1080/00952990.2021.1904408

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.912


  52 in total

Review 1.  Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Authors:  Matthew I Hardman; Juraj Sprung; Toby N Weingarten
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

2.  Analytically confirmed recreational use of Phenibut (β-phenyl-γ-aminobutyric acid) bought over the internet.

Authors:  Anselm Wong; Mark Little; David Caldicott; Chris Easton; Daniel Andres; Shaun L Greene
Journal:  Clin Toxicol (Phila)       Date:  2015-06-24       Impact factor: 4.467

3.  Phenibut, the appearance of another potentially dangerous product in the United States.

Authors:  Charles W O'Connell; Aaron B Schneir; James Q Hwang; F Lee Cantrell
Journal:  Am J Med       Date:  2014-04-05       Impact factor: 4.965

4.  Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.

Authors:  Albert Garcia-Romeu; David J Cox; Kirsten E Smith; Kelly E Dunn; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2020-02-03       Impact factor: 4.492

Review 5.  Tianeptine Abuse and Dependence in Psychiatric Patients: A Review of 18 Case Reports in the Literature.

Authors:  Janusz Springer; Wiesław Jerzy Cubała
Journal:  J Psychoactive Drugs       Date:  2018-03-01

6.  Acute behavioural disturbance associated with phenibut purchased via an internet supplier.

Authors:  Michael A Downes; Ingrid L Berling; Ahmed Mostafa; Jeffrey Grice; Michael S Roberts; Geoffrey K Isbister
Journal:  Clin Toxicol (Phila)       Date:  2015-06-26       Impact factor: 4.467

7.  The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.

Authors:  Benjamin Adam Samuels; Katherine M Nautiyal; Andrew C Kruegel; Marjorie R Levinstein; Valerie M Magalong; Madalee M Gassaway; Steven G Grinnell; Jaena Han; Michael A Ansonoff; John E Pintar; Jonathan A Javitch; Dalibor Sames; René Hen
Journal:  Neuropsychopharmacology       Date:  2017-03-17       Impact factor: 7.853

Review 8.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

9.  Phenibut dependence.

Authors:  Andriy V Samokhvalov; C Lindsay Paton-Gay; Kam Balchand; Jürgen Rehm
Journal:  BMJ Case Rep       Date:  2013-02-06

10.  Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.

Authors:  Rhiannon Bath; Tanner Bucholz; Amy F Buros; Darshan Singh; Kirsten E Smith; Charles A Veltri; Oliver Grundmann
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

View more
  6 in total

1.  Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Justin C Strickland
Journal:  J Psychoactive Drugs       Date:  2021-11-29

2.  Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample.

Authors:  Jeffrey M Rogers; Kirsten E Smith; Justin C Strickland; David H Epstein
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

Review 3.  Understanding Kratom Use: A Guide for Healthcare Providers.

Authors:  Marc T Swogger; Kirsten E Smith; Albert Garcia-Romeu; Oliver Grundmann; Charles A Veltri; Jack E Henningfield; Lorna Y Busch
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

4.  Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Kelly E Dunn; Oliver Grundmann; Christopher R McCurdy; Destiny Schriefer; David H Epstein
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

5.  For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.

Authors:  Jeffrey M Rogers; Kirsten E Smith; Destiny Schriefer; David H Epstein
Journal:  Subst Abuse       Date:  2022-09-28

6.  Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Destiny Schriefer; Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.